Stage II-III Non-small Cell Lung Cancer Clinical Trials in Shanghai

Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)